An Efficacy Study of JNJ-39220675 and Pseudoephedrine in Participants With Allergic Rhinitis
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the relative efficacy of JNJ- 39220675 and
pseudoephedrine compared to placebo (medication with no active ingredients) in participants
with allergic rhinitis (inflammation of the nose due to exposure to allergens such as pollen,
dust or animal hair).
Phase:
Phase 2
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.